no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
AIDS and HIV vaccines
|
Klein, Michel |
|
1999 |
17 |
S2 |
p. S65-S70 6 p. |
article |
2 |
BERNA: a century of immunobiological innovation
|
Cryz Jr, Stanley J |
|
1999 |
17 |
S2 |
p. S1-S5 5 p. |
article |
3 |
Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine
|
Levine, Myron M. |
|
1999 |
17 |
S2 |
p. S22-S27 6 p. |
article |
4 |
Genetically derived toxoids for use as vaccines and adjuvants
|
Del Giudice, Giuseppe |
|
1999 |
17 |
S2 |
p. S44-S52 9 p. |
article |
5 |
Glycoprotein conjugate vaccines
|
Lindberg, Alf A. |
|
1999 |
17 |
S2 |
p. S28-S36 9 p. |
article |
6 |
HIV-1 DNA vaccines and chemokines
|
Boyer, Jean D. |
|
1999 |
17 |
S2 |
p. S53-S64 12 p. |
article |
7 |
Immunotherapy of sepsis: flawed concept or faulty implementation?
|
Cross, Alan S. |
|
1999 |
17 |
S2 |
p. S13-S21 9 p. |
article |
8 |
Improving immunization strategies in developed countries
|
Schaad, Urs B. |
|
1999 |
17 |
S2 |
p. S71-S73 3 p. |
article |
9 |
Principles of transcutaneous immunization using cholera toxin as an adjuvant
|
Scharton-Kersten, Tanya |
|
1999 |
17 |
S2 |
p. S37-S43 7 p. |
article |
10 |
The potential to control or eradicate infectious diseases through immunisation
|
Widdus, R |
|
1999 |
17 |
S2 |
p. S6-S12 7 p. |
article |